Imaging developing brain infarction

Current Opinion in Neurology

Volumn 12, Issue 1, 1999, Pages 65-71

  Baird, Alison E ^a   Warach, Steven ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTIOXIDANT; CYSTEINE ETHYL ESTER TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; OXYGEN; STREPTOKINASE;

ANGIOGRAPHY; BLOOD CLOT LYSIS; BRAIN INFARCTION; BRAIN METABOLISM; COMPUTER ASSISTED TOMOGRAPHY; HEMOPERFUSION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; PATHOPHYSIOLOGY; PATIENT SELECTION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

BRAIN; CEREBRAL INFARCTION; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER;

EID: 0033017506     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199902000-00011     Document Type: Review

References (56)

1. 1 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Eng J Med 1995; 333:1581-1587.
2. 2 Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Safety and efficacy of intravenous thrombolysis with a recombinant plasminogen activator in the treatment of acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). Jama 1995; 274:1017-1025.
3. 3 von Kummer R, Holle R, Grzyska U, Hofmann E, Jansen O, Petersen D, et al. Interobserver agreement in assessing early CT signs of middle cerebral artery infarction. Am J Neuroradiology 1996; 17:1743-1748.
4. 4 Behrens S, Daffertshofer M, Spiegel D, Hennerici M. Acceleration of thrombolysis with transcranial low-frequency ultrasound in vitro [abstract]. Neurology 1998; 50(Suppl 4):A260.
5. 5 Baumgartner RW, Gönner F, Arnold M, Müri RM. Transtemporal power-and frequency-based color-coded duplex sonography of cerebral veins and sinuses. Am J Neuroradiology 1997; 18:1771-1781.
6. 6 Hunter GJ, Hamberg LM, Ponzo JA, Hüang-Hellinger FR, Morris PP, Rabinov J, et al. Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. Am J Neuroradiology 1998; 19:29-37. This is an early report of perfusion imaging using helical CT during the bolus infusion of contrast. The attraction of this method is that CT is routinely used in clinical practice. The authors propose that the quantitative map of perfused cerebral blood volume could be compared with the extent of early infarct signs to assess the proportions of infarcted tissue and tissue that is at risk, but much work is required to prove assertions about tissue viability. This procedure is currently limited to single slice acquisitions.
7. 7 Knauth M, von Kummer R, Jansen O, Hähnel S, Dörfler A, Sartor K. Potential of CT angiography in acute ischemic stroke. Am J Neuroradiology 1997; 18:1001-1010. High quality images were obtained in this well conducted study. CTA was most accurate for detecting intracranial internal carotid artery disease, MCA disease, and basilar artery disease, but less so for MCA branch occlusions. CTA compared favorably with digital subtraction angiography in 11 patients, and a reliable assessment of the extent of the collateral circulation could be made. However, image postprocessing time can take up to 30 min.
8. 8 Shrier DA, Tanaka H, Numaguchi Y, Konno S, Patel U, Shibata D. CT angiography in the evaluation of acute stroke. Am J Neuroradiology 1997; 18:1011-1020.
9. 9 Warach S, Chien D, Li W, Ronthal M, Edelman RR. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology 1992; 42:1717-1723.
10. 10 Chien D, Kwong KK, Gress DR, Buonanno FS, Buxton RB, Rosen BR. MR diffusion imaging of cerebral infarction in humans. Am J Neuroradiology 1992; 13:1097-1102.
11. 11 Baird AE, Benfield A, Schlaug G, Siewert B, Lövblad KO, Edelman RR, Warach S. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997; 41:581-589.
12. 12 Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang-Hellinger FR, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echoplanar MR imaging. Radiology 1996; 199:391-401.
13. 13 Warach S, Gaa J, Siewert B, Wielpolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion weighted MRI. Ann Neurol 1995; 37:231-241.
14. 14 Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998; 18:583-609. This is a comprehensive and well-organized review of the methodology, pathophysiology, and potential clinical applications of magnetic resonance in acute stroke.
15. 15 Lövblad KO, Jakob PM, Chen Q, Baird AE, Schlaug G, Warach S, Edelman RR. Turbo spin-echo diffusion-weighted MR of ischemic stroke. Am J Neuroradiology 1998; 19:201-208. DWI half-Fourier single-shot turbo spin-echo is a fast diffusion-weighted imaging method that could be used on magnetic resonance systems that do not have EPt capability, and has fewer image distortions in the posterior fossa than EPI-DWI. However, as image acquisition is much slower (minutes) and requires cardiac gating, and because images are of lower resolution, it is not a threat to EPI-DWI which is available on the current generation of MRI scanners.
16. 16 Butts K, Pauly J, de Crespigny A, Moseley M. Isotropic diffusion-weighted and spiral-navigated interleaved EPI for routine imaging of acute stroke. Magn Res Med 1997; 38:741-749.
17. 17 Østergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 1996; 36:726-736.
18. 18 van Zijl PCM, Eleff SM, Ulatowski JA, Qja JME, Ulug AM, Traystman RJ, Kauppinen RA. Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging. Nature Med 1998; 4:159-167. This paper provides quantitative physiologic relationships that relate changes in magnetic resonance BOLD signal to changes in cerebral blood flow, cerebral blood volume, and oxygen extraction. The physiologic parameters were validated in a model of cerebral hypoxia. Potentially, quantitative values for magnetic resonance BOLD perfusion imaging could be developed for cerebral ischemia, which would be very valuable for pathophysiologic studies. So far it has been implemented on higher field magnets than used in clinical practice.
19. 19 Pouwels PJW, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Res Med 1998; 39:53-60.
20. 20 Loubinoux I, Volk A, Borredon J, Guirimand S, Tiffon B, Seylaz J, Méric P. Spreading of vasogenic edema and cytotoxic edema assessed by quantitative diffusion and T2 magnetic resonance imaging. Stroke 1997; 28:419-427.
21. 21 Kohno K, Hoehn-Berlage M, Mies G, Back T, Hossmann KA. Relationship between diffusion-weighted MR images, cerebral blood flow, and energy state in experimental brain infarction. Magn Reson Imaging 1995; 13:73-80.
22. 22 Hoehn-Berlage M, Norris DG, Kohno K, Mies G, Leibtritz D, Hossmann K-A. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction of cerebral blood flow and metabolic disturbances. J Cereb Blood Flow Metab 1995; 15:1002-1011.
23. 23 Latour L, Hasegawa Y, Formato J, Fisher M, Sotak C. Spreading waves of decreased diffusion coefficient after cortical stimulation in the rat brain. Magn Reson Med 1996; 32:189-198.
24. 24 Röther J, de Crespigny AJ, D'Arceuil H, Iwai K, Moseley ME. Recovery of apparent diffusion coefficient after ischemia-induced spreading depression relates to cerebral perfusion gradient. Stroke 1996; 27:980-987.
25. 25 Detre JA, Zager EL, Alsop DC, Harris VA, Welsh FA, Correlation of diffusion MRI and heat shock protein in a rat embolic stroke model. J Neural Sci 1997, 148:163-169.
26. 26 Gröhn OHJ, Lukkarinen JA, Oja JME, van Zijl PCM, Ulatowski JA, Traystman RJ, Kauppinen RA. Noninvasive detection of cerebral hypoperfusion and reversible ischemia from reduction In the magnetic resonance imaging relaxation time, T2. J Cereb Blood Flow Metab 1998; 18:911-920. In focal rodent ischemia, T2-weighted magnetic resonance BOLD signal changes appeared before DWI lesions. This likely represented hypoperfused, hypoxic tissue before the development of injury, as the area of reduction in T2 signal on BOLD corresponded to hypoperfusion on bolus tracking studies. Three tissue signatures were identified that may represent hypoxia, ischemic injury, and irreversible injury. These signatures could ultimately be used to guide decision making about the administration of acute stroke therapy. At present this technique is restricted to experimental ischemia but has the potential for hyperacute stroke imaging in humans and for quantitation.
27. 27 Els T, Röther J, Beaulieu C, de Crespigny A, Moseley M. Hyperglycemia delays terminal depolarization and enhances repolarization after peri-infarct spreading depression as measured by serial diffusion MR mapping. J Cereb Blood Flow Metab 1997; 17:591-595.
28. 28 Mancuso A, Nimura T, Weinstein PR. Prediction of delayed ischemic injury with diffusion-weighted MRI following temporary middle cerebral artery occlusion in rats. Brain Res 1997; 760:42-51.
29. 29 Takano K, Carano RAD, Tatlisumak T, Meiler M, Sotak CH, Kleinert HD, Fisher M. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology 1998; 50:870-875.
30. 30 Liu Y, Mituska S, Hashizume K, Hosaka T, Nukui H. The sequential change of local cerebral blood flow and local cerebral glucose metabolism after focal cerebral ischaemia and reperfusion in rat and the effect of MK-801 on local cerebral glucose metabolism. Acta Neurochurgica (Wein) 1997; 139:770-779.
31. 31 Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Correlation of perfusion-and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology 1998; 50:864-870. This paper provides clinical correlations of perfusion and DWI lesion volumes in the first 6.5 h after stroke. In most patients the hypoperfusion volume (as measured by the mean transit time) was larger than the DWI lesion volume. The hypoperfusion and DWI lesion volumes showed a significant correlation with clinical severity at 24 h and with infarct volume at 7 days. The importance of these results is that they provide preliminary evidence to support the hypothesis that the evolving DWI lesion represents the recruitment of viable tissue into the infarct. The combination of MR diffusion weighted and perfusion imaging could ultimately provide MR imaging markers for prethrombolysis patient selection.
32. 32 Kamada K, Saguer M, Möller M, Wicklow K, Katenhäuser M, Kober H, Vieth J. Functional and metabolic analysis of cerebral ischemia using magnetoencephalography and proton magnetic resonance spectroscopy. Ann Neurol 1997; 42:554-563. This is an interesting study of the relation between brain function and metabolism in subacute and chronic cerebral infarcts. In some cases tissue adjacent to the infarct had abnormal magnetoencephalography and abnormal magnetic resonance spectroscopy (reduced N-acetyl aspartate) but was morphologically normal on T2-weighted images. In other cases, abnormal magnetoencephalography was associated with mild lactic acidosis but no loss of N-acetyl compounds. Results could be due to neuronal dropout or selective neuronal loss during acute ischemia, but the abnormal magnetoencephalography indicated that the remaining neurons may be functioning abnormally. It was proposed that this tissue could represent a chronic ischemic penumbra. Demonstration of persistent hypoperfusion is required to back up this assertion.
33. 33 Bowler JV, Wade JPH, Jones BE, Nijran KS, Steiner TJ. Natural history of the spontaneous reperfusion of human cerebral infarcts as assessed by Tc-99m HMPAO SPECT. J Neurol Neurosurg Psychiatry 1998; 64:98-103.
34. 34 Baird AE, Austin MC, McKay WJ, Donnan GA. Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome. J Neurol Neurosurg Psychiatry 1996; 61:26-29.
35. 35 Baptista MV, Maeder P, Dewarrat A, Bogousslavsky J. Conflicting images (letter). Lancet 1998; 351:414.
36. 36 Haufman MJ, Levin JM, Ross MH, Lange N, Rose SL, Kukes TJ, et al. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA 1998; 279:376-380. This paper provides first proof that cocaine's effect on the cerebral vasculature is through vasoconstriction of large and medium sized arteries. The effect occurred in a dose-dependent manner. Low-dose cocaine was intravenously administered to individuals with a history of cocaine usage. How imaging modalities can be used to study mechanisms of cerebral ischemia was demonstrated.
37. 37 Powers WJ, Zivin J. Magnetic resonance imaging in acute stroke. Not ready for prime time. Neurology 1998; 50:842-843.
38. 38 Patel MR, Edelman RR, Warach S. Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke 1996; 27:2321-2324.
39. 39 Ebisu T, Tanaka C, Umeda M, Kitamura M, Fukunaga M, Aoki I, et al. Hemorrhagic and nonhemorrhagic stroke: diagnosis with diffusion-weighted and T2-weighted echo-planar MR imaging. Radiology 1997; 203:823-828.
40. 40 Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. Stroke 1995; 26:2219-2221.
41. 41 Silver B, Weber J, Fisher M. Medical therapy for ischemic stroke. Clin Neuropharmacol 1996; 19:101-128.
42. 42 von Kummer R, Allen K, Holle R, Bozzao L, Bastianello S, Manelfe C, et al. Acute stroke: Usefulness of early CT findings before thrombolytic therapy. Radiology 1997; 205:327-333. This is a well conducted, blinded analysis of the usefulness of early CT signs in 620 patients enrolled in the ECASS trial. Early CT signs were found in 267 out of 603 (44%) of patients. The rate of hemorrhagic transformation increased with increasing size of the early infarct signs. Treatment with recombinant tissue plasminogen activator increased the chance of a good outcome in patients with small areas of hypoattenuation. In patients with no early CT signs and those with large areas of hypoattenuation, recombinant tissue plasminogen activator treatment was not associated with a beneficial clinical effect and was associated with an increased risk of fatal hemorrhage. However, the interobserver agreement for the detection of signs was low (κ = 0.34), highlighting the subtle nature of these signs.
43. 43 NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke - Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997; 28:2119-2125.
44. 44 Grand M, von Kummer R, Sobesky J, Schmüling S. Heiss W-D. Early computed-tomography abnormalities in acute stroke. Lancet 1997; 350:1395-1396.
45. 45 Büttner Th, Uffmann M, Günes N, Köster O. Early CCT signs of supratentorial brain infarction: clinico-radiological correlations. Acta Neurol Scand 1997; 96:317-323.
46. 46 Gholkar A, Davis M, Barer D, Mendelow AD. Early computed-tomography abnormalities in acute stroke (letter). Lancet 1998; 351:679.
47. 47 Singer MB, Chong J, Lu D, Schonewille WJ, Tuhrim S, Atlas SW. Diffusion-weighted MRI in acute subcortical infarction. Stroke 1998; 29:133-136.
48. 48 Brunberg JA, Chenevert TL, McKeever PE, Ross DA, Junck LR, Muraszko KM, et al. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: Correlation with structural alteration in gliomas of cerebral hemispheres. Am J Neuroradiology 1995; 16:361-371.
49. 49 Kishibayashi J, Segawa F, Kamada K, Sunohara N. Study of diffusion weighted magnetic resonance imaging in Wilson's disease. Rinsho Shinkeigaku 1993; 33:1086-1089.
50. 50 Bahn MM, Kido DK, Lin W, Pearlman AL. Brain magnetic resonance diffusion abnormalities in Creutzfeldt-Jakob disease. Arch Neurol 1997; 54:1411-1415.
51. 51 Marks MP, de Crespigny AJ, Lentz D, Enzmann DR, Albers GW, Moseley ME. Acute and chronic stroke: navigated spin-echo diffusion-weighted MR imaging. Radiology 1996; 199:403-408.
52. 52 Connelly A, Chong WK, Johnson CL, Ganesan V, Gadian DG, Kirkham FJ. Diffusion weighted magnetic resonance imaging of compromised tissue in stroke. Arch Dis Child 1997; 77:38-41.
53. 53 Sibony O, Stempfle N, Luton D, Oury JF, Blot PH. In utero fetal cerebral intraparenchymal ischemia diagnosed by nuclear magnetic resonance. Devel Med Child Neurol 1998; 40:122-123.
54. 54 Lövblad KO, Baird AE, Schlaug G, Siewert B, Benfield A, Connor A, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997; 42:164-170. In this large series, DWI lesion volumes measured during the first 24 h correlated significantly with acute and outcome clinical severity. The clinicoradiologic correlations became more significant when patients with lacunar ischemia were excluded.
55. 55 Berrouschot J, Barthel H, Hesse S, Köster J, Knapp WH, Schneider D. Differentiation between transient ischemic attack and ischemic stroke within the first six hours after onset of symptoms by using 99mTc-ECD SPECT. J Cereb Blood Flow Metab 1998; 18:921-929.
56. 56 Yasaka M, O'Keefe GJ, Chambers BR, Davis SM, Infeld B, O'Malley H, et al. Streptokinase in acute stroke. Effect on reperfusion and recanalization. Neurology 1998; 50:626-632. Randomized, placebo-controlled, and blinded measurements of reperfusion and arterial recanalization in the Australian Streptokinase Trial showed higher rates of reperfusion/recanalization in streptokinase-treated patients.